Sponsor / Institution

United States Department of Defense

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All Programs Therapeutics Devices

Open filtered programs

Programs

linked to organization

Strong Evidence

0 status confirmed

Details Checked

0 open data checks

Company / Institution Links

0 / 1

industry vs non-industry records

Competitive Density

Pipeline Velocity

Completion Signal

Programs by Stage

Phase 21

Trial / Program Status

Discontinued1

Modality Mix

Small Molecule1

Indication Coverage

Hearing Loss1

Noise-Induced Hearing Loss1

Sensorineural Hearing Loss1

Program Types

Therapeutic1

Population Tags

acute-noise-exposure1

adult1

noise-induced1

otoprotection1

Strong-Evidence Records

0 records

No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks

Washington University/Gateway zonisamide acute noise-induced hearing loss studies

Details checked

Small MoleculePhase 2Discontinued

Oral zonisamide, a commercially available sulfonamide anticonvulsant/carbonic anhydrase inhibitor, evaluated as a preventive treatment for acute noise-induced hearing loss after firearm training or skull-base surgical drilling.

Data checks: institution-led-study, industry-collaborator-not-primary-sponsor